This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hauber, J Articles by Cullen, B R Search for Related Content PubMed PubMed Citation Articles by Hauber, J Articles by Cullen, B R

 Previous Article  |  Next Article 

J Virol. 1988 March; 62(3): 673-679

Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type I long terminal repeat.

Department of Molecular Genetics, Hoffmann-La Roche Inc., Nutley, New Jersey 07110.

ABSTRACT

We used site-directed mutagenesis to delineate sequences within the human immunodeficiency virus type I (HIV-I) long terminal repeat (LTR) required for trans-activation by the viral tat gene product. We demonstrated that sequences 3' to LTR position +44 are dispensable for trans-activation but that almost all of the mutations tested located between positions -17 and +44 greatly reduced trans-activation at both the transcriptional and posttranscriptional levels. However, displacement of the HIV-I LTR trans-activation-responsive region (TAR) 3' by insertion of up to 32 base pairs between the LTR TATA box and cap site had little effect on trans-activation. An analysis of the DNase I hypersensitivity profile of the HIV-I LTR in transfected cultures suggested the presence of at least two DNase I-hypersensitive sites, including one which extends into the viral TAR element; however, neither of these sites appeared to be significantly affected by tat coexpression. These results allow more precise delineation of the sequences important for TAR function and suggest that the TAR may be recognized by a host-specific DNA-binding protein rather than by the tat protein directly.

This article has been cited by other articles:

• Sancho, R., de la Vega, L., Macho, A., Appendino, G., Di Marzo, V., Munoz, E. (2005). Mechanisms of HIV-1 Inhibition by the Lipid Mediator N-Arachidonoyldopamine. J. Immunol. 175: 3990-3999 [Abstract] [Full Text]  
• Leonard, J. N., Schaffer, D. V. (2005). Computational Design of Antiviral RNA Interference Strategies That Resist Human Immunodeficiency Virus Escape. J. Virol. 79: 1645-1654 [Abstract] [Full Text]  
• Sancho, R., Marquez, N., Gomez-Gonzalo, M., Calzado, M. A., Bettoni, G., Coiras, M. T., Alcami, J., Lopez-Cabrera, M., Appendino, G., Munoz, E. (2004). Imperatorin Inhibits HIV-1 Replication through an Sp1-dependent Pathway. J. Biol. Chem. 279: 37349-37359 [Abstract] [Full Text]  
• Scheef, G., Fischer, N., Flory, E., Schmitt, I., Tonjes, R. R. (2002). Transcriptional Regulation of Porcine Endogenous Retroviruses Released from Porcine and Infected Human Cells by Heterotrimeric Protein Complex NF-Y and Impact of Immunosuppressive Drugs. J. Virol. 76: 12553-12563 [Abstract] [Full Text]  
• Dang, Q., Hu, W.-S. (2001). Effects of Homology Length in the Repeat Region on Minus-Strand DNA Transfer and Retroviral Replication. J. Virol. 75: 809-820 [Abstract] [Full Text]  
• Kashanchi, F., Agbottah, E. T., Pise-Masison, C. A., Mahieux, R., Duvall, J., Kumar, A., Brady, J. N. (2000). Cell Cycle-Regulated Transcription by the Human Immunodeficiency Virus Type 1 Tat Transactivator. J. Virol. 74: 652-660 [Abstract] [Full Text]  
• Trubetskoy, A. M., Okenquist, S. A., Lenz, J. (1999). R Region Sequences in the Long Terminal Repeat of a Murine Retrovirus Specifically Increase Expression of Unspliced RNAs. J. Virol. 73: 3477-3483 [Abstract] [Full Text]  
• Daviet, L., Bois, F., Battisti, P.-L., Gatignol, A. (1998). Identification of Limiting Steps for Efficient Trans-activation of HIV-1 Promoter by Tat in Saccharomyces cerevisiae. J. Biol. Chem. 273: 28219-28228 [Abstract] [Full Text]  
• Cupelli, L., Okenquist, S. A., Trubetskoy, A., Lenz, J. (1998). The Secondary Structure of the R Region of a Murine Leukemia Virus Is Important for Stimulation of Long Terminal Repeat-Driven Gene Expression. J. Virol. 72: 7807-7814 [Abstract] [Full Text]  
• Daelemans, D., Esté, J. A., Witvrouw, M., Pannecouque, C., Jonckheere, H., Aquaro, S., Perno, C.-F., Clercq, E. D., Vandamme, A.-M. (1997). S-Adenosylhomocysteine Hydrolase Inhibitors Interfere with the Replication of Human Immunodeficiency Virus Type 1 through Inhibition of the LTR Transactivation. Mol. Pharmacol. 52: 1157-1163 [Abstract] [Full Text]  
• Liu, Y., Wang, Z., Rana, T. M. (1996). Visualizing a Specific Contact in the HIV-1 Tat Protein Fragment and trans-Activation Responsive Region RNA Complex by Photocross-linking. J. Biol. Chem. 271: 10391-10396 [Abstract] [Full Text]  
• Tiley, L S, Madore, S J, Malim, M H, Cullen, B R (1992). The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.. Genes Dev. 6: 2077-2087 [Abstract]  
• Hsu, M., Schutt, A., Holly, M, Slice, L., Sherman, M., Richman, D., Potash, M., Volsky, D. (1991). Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist. Science 254: 1799-1802 [Abstract]  
• Southgate, C D, Green, M R (1991). The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function.. Genes Dev. 5: 2496-2507 [Abstract]  
• Wu, F, Garcia, J, Sigman, D, Gaynor, R (1991). tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185.. Genes Dev. 5: 2128-2140 [Abstract]  
• Brown, P H, Tiley, L S, Cullen, B R (1991). Effect of RNA secondary structure on polyadenylation site selection.. Genes Dev. 5: 1277-1284 [Abstract]  
• Gatignol, A, Buckler-White, A, Berkhout, B, Jeang, K. (1991). Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science 251: 1597-1600 [Abstract]  
• Calnan, B J, Biancalana, S, Hudson, D, Frankel, A D (1991). Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition.. Genes Dev. 5: 201-210 [Abstract]  
• Ratnasabapathy, R, Sheldon, M, Johal, L, Hernandez, N (1990). The HIV-1 long terminal repeat contains an unusual element that induces the synthesis of short RNAs from various mRNA and snRNA promoters.. Genes Dev. 4: 2061-2074 [Abstract]  
• Laspia, M F, Rice, A P, Mathews, M B (1990). Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation.. Genes Dev. 4: 2397-2408 [Abstract]  
• Weeks, K., Ampe, C, Schultz, S., Steitz, T., Crothers, D. (1990). Fragments of the HIV-1 Tat protein specifically bind TAR RNA. Science 249: 1281-1285 [Abstract]  
• Roy, S, Delling, U, Chen, C H, Rosen, C A, Sonenberg, N (1990). A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation.. Genes Dev. 4: 1365-1373 [Abstract]  
• Nelbock, P, Dillon, P., Perkins, A, Rosen, C. (1990). A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator. Science 248: 1650-1653 [Abstract]  
• Selby, M J, Bain, E S, Luciw, P A, Peterlin, B M (1989). Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat.. Genes Dev. 3: 547-558 [Abstract]  
• Toohey, M G, Jones, K A (1989). In vitro formation of short RNA polymerase II transcripts that terminate within the HIV-1 and HIV-2 promoter-proximal downstream regions.. Genes Dev. 3: 265-282 [Abstract]  
• Varmus, H (1988). Regulation of HIV and HTLV gene expression.. Genes Dev. 2: 1055-1062  
• Jones, K A, Luciw, P A, Duchange, N (1988). Structural arrangements of transcription control domains within the 5'-untranslated leader regions of the HIV-1 and HIV-2 promoters.. Genes Dev. 2: 1101-1114 [Abstract]  
• Chen, P., Flory, E., Avots, A., Jordan, B. W. M., Kirchhoff, F., Ludwig, S., Rapp, U. R. (2000). Transactivation of Naturally Occurring HIV-1 Long Terminal Repeats by the JNK Signaling Pathway. THE MOST FREQUENT NATURALLY OCCURRING LENGTH POLYMORPHISM SEQUENCE INTRODUCES A NOVEL BINDING SITE FOR AP-1 FACTORS. J. Biol. Chem. 275: 20382-20390 [Abstract] [Full Text]  
• Holloway, A. F., Occhiodoro, F., Mittler, G., Meisterernst, M., Shannon, M. F. (2000). Functional Interaction between the HIV Transactivator Tat and the Transcriptional Coactivator PC4 in T Cells. J. Biol. Chem. 275: 21668-21677 [Abstract] [Full Text]